322 related articles for article (PubMed ID: 30808377)
1. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
[TBL] [Abstract][Full Text] [Related]
2. Predictive gamma passing rate by dose uncertainty potential accumulation model.
Shiba E; Saito A; Furumi M; Murakami Y; Ohguri T; Tsuneda M; Yahara K; Nishio T; Korogi Y; Nagata Y
Med Phys; 2019 Feb; 46(2):999-1005. PubMed ID: 30536878
[TBL] [Abstract][Full Text] [Related]
3. Independent calculation-based verification of IMRT plans using a 3D dose-calculation engine.
Arumugam S; Xing A; Goozee G; Holloway L
Med Dosim; 2013; 38(4):376-84. PubMed ID: 23790325
[TBL] [Abstract][Full Text] [Related]
4. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
5. On the use of a convolution-superposition algorithm for plan checking in lung stereotactic body radiation therapy.
Hardcastle N; Oborn BM; Haworth A
J Appl Clin Med Phys; 2016 Sep; 17(5):99-110. PubMed ID: 27685114
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
7. External beam patient dose verification based on the integral quality monitor (IQM
Mahuvava C; Du Plessis FCP
Biomed Phys Eng Express; 2020 Mar; 6(3):035014. PubMed ID: 33438659
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
9. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
11. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
[TBL] [Abstract][Full Text] [Related]
12. Quantified difference of the collapsed cone convolution (CCC) and Monte Carlo (MC) algorithms based on DVH and gamma analysis for cervical cancer radiation therapy.
Zhang R; Bai J; Wang R; Yan J; Chang L; Bai H
Appl Radiat Isot; 2024 Aug; 210():111340. PubMed ID: 38749237
[TBL] [Abstract][Full Text] [Related]
13. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
14. The 3D isodose structure-based method for clinical dose distributions comparison in pretreatment patient-QA.
Tamborra P; Martinucci E; Massafra R; Bettiol M; Capomolla C; Zagari A; Didonna V
Med Phys; 2019 Feb; 46(2):426-436. PubMed ID: 30450559
[TBL] [Abstract][Full Text] [Related]
15. Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry.
Nijsten SM; van Elmpt WJ; Mijnheer BJ; Minken AW; Persoon LC; Lambin P; Dekker AL
Med Phys; 2009 Jan; 36(1):83-94. PubMed ID: 19235376
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics.
Chen L; Luo H; Li S; Tan X; Feng B; Yang X; Wang Y; Jin F
Radiat Oncol; 2023 Nov; 18(1):192. PubMed ID: 37986008
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.
Olch AJ
Med Phys; 2012 Jan; 39(1):81-6. PubMed ID: 22225277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
